TY - JOUR
T1 - Central nervous system vasculitis caused by propylthiouracil therapy
T2 - A case report and literature review
AU - Vanek, C.
AU - Samuels, M. H.
PY - 2005/1
Y1 - 2005/1
N2 - Antineutrophil cytoplasmic antibodies (ANCA) are associated with vasculitis, including vasculitis induced by drugs such as the thionamides. The affected organ systems in thionamide-induced vasculitis have been primarily renal, musculoskeletal, and dermatologic. We describe the first case of thionamide-induced central nervous system vasculitis presenting as confusion, with complete resolution after discontinuation of propylthiouracil. We review the literature and summarize 42 additional cases of thionamide-induced ANCA-positive vasculitis since 1992. Propylthiouracil was responsible in 93% of cases and the predominant ANCA pattern on immunofluorescent staining was perinuclear (p-ANCA). Clinical improvement occurred after drug discontinuation in 93%, steroid therapy was used in some cases. The mean duration of treatment with thionamides was 35 months prior to presentation. Long-term medical treatment with thionamides for hyperthyroidism may increase the risk of this severe side effect.
AB - Antineutrophil cytoplasmic antibodies (ANCA) are associated with vasculitis, including vasculitis induced by drugs such as the thionamides. The affected organ systems in thionamide-induced vasculitis have been primarily renal, musculoskeletal, and dermatologic. We describe the first case of thionamide-induced central nervous system vasculitis presenting as confusion, with complete resolution after discontinuation of propylthiouracil. We review the literature and summarize 42 additional cases of thionamide-induced ANCA-positive vasculitis since 1992. Propylthiouracil was responsible in 93% of cases and the predominant ANCA pattern on immunofluorescent staining was perinuclear (p-ANCA). Clinical improvement occurred after drug discontinuation in 93%, steroid therapy was used in some cases. The mean duration of treatment with thionamides was 35 months prior to presentation. Long-term medical treatment with thionamides for hyperthyroidism may increase the risk of this severe side effect.
UR - http://www.scopus.com/inward/record.url?scp=13544275099&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=13544275099&partnerID=8YFLogxK
U2 - 10.1089/thy.2005.15.80
DO - 10.1089/thy.2005.15.80
M3 - Article
C2 - 15687828
AN - SCOPUS:13544275099
SN - 1050-7256
VL - 15
SP - 80
EP - 84
JO - Thyroid
JF - Thyroid
IS - 1
ER -